M. Williams

Rituximab Chimeric Anti-CD20 Monoclonal Antibody Therapy for Relapsed Indolent Lymphoma: Half of Patients Respond to a Four-Dose Treatment Program

M. Czuczman, P. Mclaughlin, F. Cabanillas, 2023, Journal of Clinical Oncology.

Dual Roles of RNF2 in Melanoma Progression.

L. Chin, J. Ernst, E. Keung, 2015, Cancer discovery.

Enhancer Reprogramming Confers Dependence on Glycolysis and IGF Signaling in KMT2D Mutant Melanoma

Min Gyu Lee, Guangchun Han, E. Keung, 2018, bioRxiv.

Drug and radiation sensitivity measurements of successful primary monolayer culturing of human tumor cells using cell-adhesive matrix and supplemented medium.

J. Ajani, P. Tofilon, S. Pathak, 1986, Cancer research.